United States · FDA National Drug Code directory
Edarbi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60631-080_2f63b0e8-977a-4d22-9550-29ad1926a9de
- Product NDC
- 60631-080
- Form
- TABLET
- Composition / generic term
- Azilsartan kamedoxomil
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130201
- Source listing expiry
- 20261231
Source-listed ingredients
- AZILSARTAN KAMEDOXOMIL — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (60631-080-30) · 60631-080-30
- 7 TABLET in 1 BOTTLE (60631-080-77) · 60631-080-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →